After Setbacks, Sanofi/GlaxoSmithKline COVID Vaccine Performs Well in Early Trial

MONDAY, May 17, 2021 — Sanofi and GlaxoSmithKline announced Monday that their coronavirus vaccine candidate produced powerful responses in a preliminary trial that followed an earlier setback in the vaccine’s development.
In selected data that has…
Source: Topamax